Overcoming resistance to PARP inhibitor in epithelial ovarian cancer, are we ready?

Por Isabelle Ray-Coquard, Hélène Vanacker, Olivia Le Saux, Olivier Tredan
Publicado em 2020-11-01

Oestrogen Non-Genomic Signalling is Activated in Tamoxifen-Resistant Breast Cancer

Por Coralie Poulard, Julien Jacquemetton, Olivier Trédan, Pascale A. Cohen, Julie Vendrell, Sandra E. Ghayad, Isabelle Treilleux, Elisabetta Marangoni, Muriel Le Romancer
Publicado em 2019-06-01

Therapeutic relevance of molecular screening program in patients with metastatic sarcoma: Analysis from the ProfiLER 01 trial

Por Patrick Arnaud-Coffin, Mehdi Brahmi, Hélène Vanacker, Lauriane Eberst, Olivier Tredan, Valery Attignon, Daniel Pissaloux, Emilie Sohier, Philippe Cassier, Gwenaelle Garin, David Pérol, Jean-Yves Blay, Armelle Dufresne
Publicado em 2020-12-01

IMPDH1/YB-1 Positive Feedback Loop Assembles Cytoophidia and Represents a Therapeutic Target in Metastatic Tumors

Por Ruan, Hailong, Song, Zhengshuai, Cao, Qi, Ni, Dong, Xu, Tianbo, Wang, Keshan, Bao, Lin, Tong, Junwei, Xiao, Haibing, Xiao, Wen, Cheng, Gong, Xiong, Zhiyong, Liang, Huageng, Liu, Di, Wang, Liang, Olivier, Tredan, Jane, Boyle Helen, Yang, Hongmei, Zhang, Xiaoping, Chen, Ke
Publicado no Mol Ther (2020)